Malta - angleščina - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - colistimethate sodium - powder for solution for injection - colistimethate sodium 1 million iu - antibacterials for systemic use

Malta - angleščina - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - colistimethate sodium - powder for solution for injection - colistimethate sodium 2 million iu - antibacterials for systemic use

Irska - angleščina - HPRA (Health Products Regulatory Authority)

noridem enterprises limited - colistimethate sodium - powder for nebuliser solution - colistin

Irska - angleščina - HPRA (Health Products Regulatory Authority)

noridem enterprises limited - colistimethate sodium - powder for nebuliser solution - colistin

Irska - angleščina - HPRA (Health Products Regulatory Authority)

noridem enterprises limited - colistimethate sodium - powder for solution for injection/infusion - colistin

Irska - angleščina - HPRA (Health Products Regulatory Authority)

noridem enterprises limited - colistimethate sodium - powder for solution for injection/infusion - colistin

Združene države Amerike - angleščina - NLM (National Library of Medicine)

heritage pharmaceuticals inc. d/b/a avet pharmaceuticals inc. - colistimethate sodium (unii: xw0e5ys77g) (colistimethate - unii:dl2r53p963) - colistimethate for injection, usp is indicated for the treatment of acute or chronic infections due to sensitive strains of certain gram-negative bacilli. it is particularly indicated when the infection is caused by sensitive strains of pseudomonas aeruginosa . this antibiotic is not indicated for infections due to proteus or neisseria . colistimethate for injection, usp has proven clinically effective in treatment of infections due to the following gram-negative organisms: enterobacter aerogenes, escherichia coli, klebsiella pneumoniae and pseudomonas aeruginosa. colistimethate for injection, usp may be used to initiate therapy in serious infections that are suspected to be due to gram-negative organisms and in the treatment of infections due to susceptible gram-negative pathogenic bacilli. to reduce the development of drug-resistant bacteria and maintain the effectiveness of colistimethate for injection, usp and other antibacterial drugs, colistimethate for injection, usp should be used only to treat or p

Združene države Amerike - angleščina - NLM (National Library of Medicine)

nexus pharmaceuticals inc - colistimethate sodium (unii: xw0e5ys77g) (colistimethate - unii:dl2r53p963) - colistimethate for injection is indicated for the treatment of acute or chronic infections due to sensitive strains of certain gram-negative bacilli. it is particularly indicated when the infection is caused by sensitive strains of pseudomonas aeruginosa . this antibiotic is not indicated for infections due to proteus or neisseria . colistimethate for injection has proven clinically effective in treatment of infections due to the following gram-negative organisms: enterobacter aerogenes, escherichia coli, klebsiella pneumoniae and pseudomonas aeruginosa. colistimethate for injection may be used to initiate therapy in serious infections that are suspected to be due to gram-negative organisms and in the treatment of infections due to susceptible gram-negative pathogenic bacilli. to reduce the development of drug-resistant bacteria and maintain the effectiveness of colistimethate for injection and other antibacterial drugs, colistimethate for injection should be used only to treat or prevent infections that are

Združene države Amerike - angleščina - NLM (National Library of Medicine)

paddock laboratories, llc - colistimethate sodium (unii: xw0e5ys77g) (colistimethate - unii:dl2r53p963) - colistin 150 mg in 2 ml

Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - colistimethate sodium - powder for solution for injection - 1000000unit